Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: The potential role of interleukin-10

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Capkova, Jana ^a   Hrncir, Tomas ^b   Kubatova, Alena ^a   Tlaskalova Hogenova, Helena ^b  

^a INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING ENTHESOPATHY; ANKYLOSING SPONDYLITIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENTHESOPATHY; FLOW CYTOMETRY; HELPER CELL; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; SPLEEN; SPONDYLITIS, ANKYLOSING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84862488189     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-110     Document Type: Article

References (39)

1. Ankylosing spondylitis and HL-A 27. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD, Lancet 1973 1 904 907
2. High association of an HL-A antigen, W27, with ankylosing spondylitis. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM, N Engl J Med 1973 288 704 706
3. Animal models of HLA-B27-associated diseases. Breban M, Hacquard-Bouder C, Falgarone G, Curr Mol Med 2004 4 31 40
4. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. Khare SD, Luthra HS, David CS, J Exp Med 1995 182 1153 1158
5. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Nordling C, Karlsson-Parra A, Jansson L, Holmdahl R, Klareskog L, Arthritis Rheum 1992 35 717 722
6. Animal models of spondyloarthritis. Taurog JD, Adv Exp Med Biol 2009 649 245 254
7. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M, Arthritis Rheum 2003 48 523 533 (Pubitemid 36278022)
8. The cutting edge of spondylarthropathy research in the millennium. Granfors K, Marker-Hermann E, de Keyser F, Khan MA, Veys EM, Yu DT, Arthritis Rheum 2002 46 606 613 (Pubitemid 34214242)
9. Histopathology of murine ankylosing enthesopathy. Eulderink F, Ivanyi P, Weinreich S, Pathol Res Pract 1998 194 797 803 (Pubitemid 28525925)
10. H-2 influence on ankylosing enthesopathy of the ankle (ANKENT). Capkova J, Ivanyi P, Folia Biol (Praha) 1992 38 258 262
11. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Weinreich S, Eulderink F, Capkova J, Pla M, Gaede K, Heesemann J, van Alphen L, Zurcher C, Hoebe-Hewryk B, Kievits F, et al. Hum Immunol 1995 42 103 115
12. Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice. Capkova J, Ivanyi P, Rehakova Z, Ann Rheum Dis 2006 65 130 132 (Pubitemid 41815656)
13. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Rehakova Z, Capkova J, Stepankova R, Sinkora J, Louzecka A, Ivanyi P, Weinreich S, Hum Immunol 2000 61 555 558 (Pubitemid 30346481)
14. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Sinkorova Z, Capkova J, Niederlova J, Stepankova R, Sinkora J, Hum Immunol 2008 69 845 850
15. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, et al. Immunol Lett 2004 93 97 108 (Pubitemid 38678650)
16. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Munford RS, Infect Immun 2008 76 454 465 (Pubitemid 351251715)
17. The relationships among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challenge in vivo. Mishima S, Xu D, Lu Q, Deitch EA, J Trauma 1998 44 175 182 (Pubitemid 28095840)
18. Uber die Extraktion von Bakterien mit Phenol/Wasser. Westphal O, Luderitz O, Bister F, Z Naturforsch 1952 7 148 155
19. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Aird WC, Blood 2003 101 3765 3777 (Pubitemid 36857845)
20. LPS induction of gene expression in human monocytes. Guha M, Mackman N, Cell Signal 2001 13 85 94 (Pubitemid 32222977)
21. Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Holmdahl R, Jansson L, Andersson M, Jonsson R, Clin Exp Immunol 1992 88 467 472
22. Grouped caging predisposes male mice to ankylosing enthesopathy. Weinreich S, Capkova J, Hoebe-Hewryk B, Boog C, Ivanyi P, Ann Rheum Dis 1996 55 645 647 (Pubitemid 26316282)
23. Animal models of HLA-B27-associated diseases: new outcomes. Hacquard-Bouder C, Ittah M, Breban M, Joint Bone Spine 2006 73 132 138
24. HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides. Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Messerini L, Matucci-Cerinic M, Ann N Y Acad Sci 2009 1173 570 574
25. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD, Infect Immun 1998 66 6022 6023 (Pubitemid 28531869)
26. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB, J Clin Invest 1996 98 945 953 (Pubitemid 26293312)
27. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE, J Exp Med 1994 180 2359 2364 (Pubitemid 24351619)
28. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, Peralta S, Franco V, Giardina E, Craxi A, et al. Arthritis Rheum 2009 60 955 965
29. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M, J Rheumatol 2000 27 2860 2865
30. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases. Faustini F, Zoli A, Ferraccioli GF, Eur Rev Med Pharmacol Sci 2009 13 Suppl 1 1 9
31. The intimate relationship between gut and joint in spondyloarthropathies. Jacques P, Mielants H, Coppieters K, De Vos M, Elewaut D, Curr Opin Rheumatol 2007 19 353 357 (Pubitemid 46884190)
32. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). Palm O, Moum B, Ongre A, Gran JT, J Rheumatol 2002 29 511 515 (Pubitemid 34202820)
33. Rheumatic manifestations of inflammatory bowel disease. Rodriguez-Reyna TS, Martinez-Reyes C, Yamamoto-Furusho JK, World J Gastroenterol 2009 15 5517 5524
34. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Biswas A, Wilmanski J, Forsman H, Hrncir T, Hao L, Tlaskalova-Hogenova H, Kobayashi KS, Eur J Immunol 2011 41 182 194
35. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A, Eur J Immunol 1995 25 2888 2893
36. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Zhang WJ, Wei H, Hagen T, Frei B, Proc Natl Acad Sci U S A 2007 104 4077 4082 (Pubitemid 47181581)
37. Tumor necrosis factor (TNF). Old LJ, Science 1985 230 630 632 (Pubitemid 16190956)
38. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Oldfield V, Plosker GL, BioDrugs 2009 23 125 135
39. Developments in the scientific and clinical understanding of the spondyloarthritides. Sieper J, Arthritis Res Ther 2009 11 208